COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors

COVID-19 convalescent plasma (CCP) is currently under investigation for both treatment and post-exposure prophylaxis. The active component of CCP mediating improved outcome is commonly reported as specific antibodies, particularly neutralizing antibodies, with clinical efficacy characterized accordi...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Franchini, Massimo, Pirofski, Liise-anne, Burnouf, Thierry, Fairweather, DeLisa, Joyner, Michael J., Casadevall, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402718/
https://www.ncbi.nlm.nih.gov/pubmed/34452459
http://dx.doi.org/10.3390/v13081594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402718/
https://www.ncbi.nlm.nih.gov/pubmed/34452459
http://dx.doi.org/10.3390/v13081594

Ejemplares similares